Expertise

Muriel advises on individual and collective labour law. She is specialised in advising on employment law and employee data protection law-related aspects of complex compliance investigations, works constitution law, transactions as well as on European labour law.

Vita

Muriel studied at the University of Konstanz and the College of Europe, Bruges (LL.M. 2004). She has been with Gleiss Lutz since 2010.

Muriel is a member of the German Bar Association’s Labour Law Working Group.

Muriel speaks German, English and French.

News
Gleiss Lutz advises bidder Telefónica on billion-euro public acquisition offer Mandate
Gleiss Lutz advises Colas Rail on the acquisition of Hasselmann Group Mandate
Gleiss Lutz advises Nova on the acquisition of ancosys Mandate
Gleiss Lutz advises Burda Digital SE on delisting offer to shareholders of listed HolidayCheck Group AG Mandate
Gleiss Lutz advises founder and shareholder Dr. Ingmar Hoerr in connection with CureVac’s IPO on the New York stock exchange Nasdaq Mandate
Expansion of strategically important practices and offices: Gleiss Lutz appoints five partners and seven counsel Article

All news

Expertise

Muriel advises on individual and collective labour law. She is specialised in advising on employment law and employee data protection law-related aspects of complex compliance investigations, works constitution law, transactions as well as on European labour law.

Vita

Muriel studied at the University of Konstanz and the College of Europe, Bruges (LL.M. 2004). She has been with Gleiss Lutz since 2010.

Muriel is a member of the German Bar Association’s Labour Law Working Group.

Muriel speaks German, English and French.

News
Gleiss Lutz advises bidder Telefónica on billion-euro public acquisition offer Mandate
Gleiss Lutz advises Colas Rail on the acquisition of Hasselmann Group Mandate
Gleiss Lutz advises Nova on the acquisition of ancosys Mandate
Gleiss Lutz advises Burda Digital SE on delisting offer to shareholders of listed HolidayCheck Group AG Mandate
Gleiss Lutz advises founder and shareholder Dr. Ingmar Hoerr in connection with CureVac’s IPO on the New York stock exchange Nasdaq Mandate
Expansion of strategically important practices and offices: Gleiss Lutz appoints five partners and seven counsel Article

All news